Adimmune Corporation

Adimmune Corporation

Share · TW0004142005 (XTAI)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Adimmune Corporation
No Price
Closing Price XTAI 29.04.2026: 17,95 TWD
29.04.2026 05:30
Current Prices from Adimmune Corporation
ExchangeTickerCurrencyLast TradePriceDaily Change
XTAI: TWSE
TWSE
4142.TW
TWD
29.04.2026 05:30
17,95 TWD
-0,05 TWD
-0,28 %
Share Float & Liquidity
Free Float 82,37 %
Shares Float 347,2 M
Shares Outstanding 421,51 M
Invested Funds

The following funds have invested in Adimmune Corporation:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
77,35
Percentage (%)
0,08 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
13,27
Percentage (%)
0,0043 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
67,19
Percentage (%)
0,0043 %
Company Profile for Adimmune Corporation Share
Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.

Company Data

Name Adimmune Corporation
Company Adimmune Corporation
Website https://www.adimmune.com.tw
Primary Exchange XTAI TWSE
ISIN TW0004142005
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Chi-Hsien Chan
Market Capitalization 8 Mrd.
Country Taiwan
Currency TWD
Employees 0,6 T
Address No. 3, Tanxing Road, 427003 Taichung
IPO Date 2012-05-03
Dividends from 'Adimmune Corporation'
Ex-Date Dividend per Share
14.09.2021 0,50 TWD

Stock Splits

Date Split
18.04.2019 1053:1000

Ticker Symbols

Name Symbol
TWSE 4142.TW
More Shares
Investors who hold Adimmune Corporation also have the following shares in their portfolio:
BL SIC.-EQUIT. EUROPE BI
BL SIC.-EQUIT. EUROPE BI Fund
RADIKO HOLDINGS CORP
RADIKO HOLDINGS CORP Share